MILLENIUM BIOLOGIX RECEIVES CE MARK FOR PRIMACOLL

Millenium Biologix announced that it has received CE mark approval for Primacoll, allowing the company to launch its second product line in Europe. Primacoll consists of a synthetically manufactured bioactive peptide combined with Skelite, Millenium's commercially available bone graft substitute. The combination is particularly effective in the initial stages of bone repair.

Canada NewsWire (http://www.newswire.ca/en/releases/archive/June2005/27/c6314.html)